Adventures of 32 Years of Medical Device and Biotech Product Development-Vytas Pazemenas-11/11/2008 - 6:00pm

Event Information
Event Topic: 
Adventures of 32 Years of Medical Device and Biotech Product Development
Event Date: 
11/11/2008 - 6:00pm
Event Location: 
Palo Alto
Speaker Information
Event Speaker: 
Vytas Pazemenas
Event Speaker Title: 
Founder and President
Event Speaker Company: 
Aubrey Group
Event Speaker Bio: 

Vytas Pazemenas is the founder and president of Aubrey Group. He has over 30 years experience in development of medical devices, biotech equipment, computer systems, and sensors.

He has led teams that developed and introduced into the marketplace more than 50 new medical products and has gained extensive experience in working with the FDA, TÜV, BSI, and other international regulatory agencies. His design experience includes blood pumps, ventricular assist device controllers, infusion pumps, pulse oximeters, ultrasound ablation systems, patient monitors, medical sensors, signal processing algorithms, analog and digital circuits, patient isolation systems, military sensor systems, RF communications systems, and various other medical systems.

His previous management experience includes serving as Manager, Infusion Systems, for Abbott Laboratories, as Director, Design Engineering, for Nellcor, as Vice President, Engineering, for CareLink, and as Vice President, R&D, for Tokos Medical.

He is also a guest lecturer in Biomedical Engineering at University of California, Irvine. Vytas holds five patents, three in sensors and two in medical devices. He received a BSEE from Penn State and an MSEE from the University of Santa Clara.

Event Details
Cost: 
$6 - Students/In-transition
$11 - Early-bird Registration
$20 - Late Registration
$25 - Walk-ins
Event Details: 

Fun, adventures, and lessons learned from 32 years of experience in developing medical devices while employed by four California startups and while, as founder of my own contract engineering and manufacturing firm, developing products for 54 medical device and biotech startup companies and 7 established medical device and pharmaceutical companies.